News | April 12, 2026
C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The company says the platform offers improved manufacturability and functional advantages
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
Subscribe To Our Newsletter & Stay Updated
